Back to the feed
In brief
On 06.10.2026, a person holding the function "Executive member of the board of directors / senior management" at Kuros Biosciences AG disclosed a sale worth CHF 552’000 to SIX Exchange Regulation.
By amount, this ranks #6 of 10 management sales disclosed at Kuros Biosciences AG over the previous 12 months.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Kuros Biosciences AG declared a "Sale" transaction on 06.10.2026.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date06.10.2026
Issuing companyKuros Biosciences AG
ISINCH0325814116
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity30’000
Unit priceCHF 18.40
AmountCHF 552’000
ConditionsBlock sale of 30'000 shares at CHF 18.40 per share
to a strategic institutional investor to cover tax
obligations.
ExchangeXSWX
Notification IDT1QA600011
Other Kuros Biosciences AG insider transactions
- Purchase · Executive member of the board of directors / senior management19.10.2026CHF 282’505
- Purchase · Executive member of the board of directors / senior management22.09.2026CHF 30’600
- Purchase · Executive member of the board of directors / senior management17.09.2026CHF 115’322
- Sale · Executive member of the board of directors / senior management26.05.2026CHF 139’385
- Purchase · Executive member of the board of directors / senior management16.03.2026CHF 65’224
These figures aggregate public disclosures. They are not investment advice.